New strategies to interfere with radiation response: « Biomodulation» of radiation therapy;Les stratégies nouvelles pour moduler les effets de l'irradiation: Exemples d'interactions entre biomodulateurs et radiothérapie

Cancer/Radiotherapie

Volumn 9, Issue 2, 2005, Pages 139-146

  Deutsch, E ^a   Kaliski, A ^a   Maggiorella, L ^a   Bourhis, J ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Angiogenesis; Cyclooxygenase 2; Insulin Growth Factor 1; New drugs; Radiation resistance; Radiation therapy; Targeted therapies

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;

ANGIOGENESIS; CANCER; CANCER GROWTH; CANCER RADIOTHERAPY; CELL VIABILITY; CYTOTOXICITY; GENE MUTATION; HUMAN; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 16844361931     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2004.12.002     Document Type: Short Survey

References (32)

1. A. Abdollahi, K.E. Lipson, X. Han, R. Krempien, T. Trinh, and K.J. Weber SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro Cancer. Res. 13 2003 3755 3763
2. B. Abdulkarim, and E. Deutsch Endothelial-cell apoptosis and tumour response to radiotherapy Lancet Oncol. 1 2004 9
3. R. Baserga, F. Peruzzi, and K. Reiss The IGF-1 receptor in cancer biology Int. J. Cancer 6 2003 873 877
4. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat. Rev Cancer. 6 2003 401 410
5. G. Bowers, D. Reardon, T. Hewitt, P. Dent, R.B. Mikkelsen, and K. Valerie The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells Oncogene 20 2001 1388 1397
6. P. Carmeliet Angiogenesis in health and disease Nat. Med. 6 2003 653 660
7. F. Cianchi, C. Cortesini, O. Fantappie, L. Messerini, I. Sardi, and N. Lasagna Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer Clin. Cancer Res. 2004
8. M. Cianfrocca, T.P. Cooley, J.Y. Lee, M.A. Rudek, D.T. Scadden, and L. Ratner Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study J. Clin. Oncol. 1 2002 153 159
9. D.L. Dugle, C.J. Gillespie, and J.D. Chapman DNA strand breaks, repair, and survival in x-irradiated mammalian cells Proc. Natl. Acad. Sci. USA 3 1998 809 812
10. A. Eberhard, S. Kahlert, V. Goede, B. Hemmerlein, K.H. Plate, and H.G. Augustin Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies Cancer Res. 5 1999 1388 1393
11. B. Fertil, and P.J. Deschavanne Relationships between colony forming efficiency and parameters of intrinsic radiosensitivity Int. J. Radiat. Biol. 10 1999 1275 1282
12. Y.D. Jung, K. Nakano, W. Liu, G.E. Gallick, and L.M. Ellis Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells Cancer Res. 19 2001 4804 4807
13. J. Folkman Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 21 1971 1182 1186
14. M. Garcia-Barros, F. Paris, C. Cordon-Cardo, D. Lyden, S. Rafii, and A. Haimovitz-Friedman Tumor response to radiotherapy regulated by endothelial cell apoptosis Science 5622 2003 1155 1159
15. D.H. Gorski, M.A. Beckett, N.T. Jaskowiak, D.P. Calvin, H.J. Mauceri, and R.M. Salloum Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation Cancer Res. 59 1999 3374 3378
16. D.H. Gorski, H.J. Mauceri, R.M. Salloum, S. Gately, S. Hellman, and M.A. Beckett Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin Cancer Res. 58 1998 5686 5689
17. K. In-Ah, W. Jun-Min, A. Fernandes, K. Cengel, A. Gupta, and R. Muschel Selective inhibition of Ras-PI3 Kinase-Akt pathway components increases the radiosensitivity of human carcinoma cell lines Proceedings American Assoc. Canc. Res 2004 Univ. of Pennsylvania, Philadelphia, PA. Philadelphie USA 511
18. R.K. Jain Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy Nat. Med. 9 2001 987 989
19. A. Kaliski, E. Deutsch, D. Math́, L. Maggiorella, V. Frascogna, and J. Bourhis Metastat abrogates radiation-induced invasiveness through interference with a radiation-enhanced MMP proteolytic system AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics, Boston 2003 322
20. C.G. Lee, M. Heijn, E. Di Tomaso, G. Griffon-Etienne, M. Ancukiewicz, and C. Koike Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions Cancer Res. 60 2000 5565 5570
21. D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 4935 1989 1306 1309
22. T.J. Lynch, D.W. Bell, R. Sordella, S. Gurubhagavatula, R.A. Okimoto, and B.W. Brannigan Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 21 2004 2129 2139
23. H.J. Mauceri, N.N. Hanna, J.D. Wayne, D.E. Hallahan, S. Hellman, and R.R. Weichselbaum Tumor necrosis factor α(TNF-α) gene therapy targeted by ionizing radiation selectively damages tumor vasculature Cancer Res. 56 1996 4311
24. E. Nakata, K.A. Mason, N. Hunter, A. Husain, U. Raju, and Z. Liao Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors Int. J. Radiat. Oncol. Biol. Phys. 2 2004 369 375
25. R.M. Shaheen, W.W. Tseng, D.W. Davis, W. Liu, N. Reinmuth, and R. Vellagas Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms Cancer Res. 61 2001 1464 1468
26. D.W. Siemann, and A.M. Rojiani Enhancement of radiation therapy by the novel vascular targeting agent ZD6126 Int. J. Radiat. Oncol. Biol. Phys. 53 2002 164 171
27. B.A. Teicher, S.A. Holden, G. Ara, N.P. Dupuis, F. Liu, and J. Yuan Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy Int. J. Cancer 5 2000 732 737
28. G.M. Tozer, V.E. Prise, J. Wilson, R.J. Locke, B. Vojnovic, and M.R. Stratford Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues Cancer Res. 59 1999 1626 1634
29. B. Valentinis, and R. Baserga IGF-I receptor signalling in transformation and differentiation Mol. Pathol. 3 2001 133 137
30. P. Wachsberger, R. Burd, and A.P. Dicker Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction Clin. Cancer Res. 6 2003 1957 1971
31. B. Wen, E. Deutsch, P. Eschwege, R. De Crevoisier, E. Nasr, and F. Eschẁge Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells J. Urol. 5 2003 2036 2039
32. B. Wen, E. Deutsch, E. Marangoni, V. Frascona, L. Maggiorella, and B. Abdulkarim Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells Br. J. Cancer 12 2001 2017 2021